Eli Lilly Sues Six Companies Over Alleged Illegal Sales of Experimental Obesity Drug Retatrutide
Aug 12, 2026
Eli Lilly sued six companies for illegally selling unapproved black-market versions of its experimental obesity drug retatrutide, currently in Phase 3 trials. Highlighting safety risks, the firm urged regulators to curb illicit trade following intercepts of over 90,000 units.